Ocular Adnexal Mucosa-associated Lymphoid Tissue Lymphoma
📧 Sign up to get email alerts when something new happens for Ocular Adnexal Mucosa-associated Lymphoid Tissue Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-08-04Clinical Trial Update: Intralesional Rituximab for the Treatment of Conjunctival Indolent Lymphoma [Phase 2]
Phase 2 trial evaluating intralesional rituximab for conjunctival indolent lymphoma shows completion of the study.